Technology area: Biotechnology & Pharmaceuticals
31 pending office actions • 28 art units • 30 examiners • 0 of 31 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days
University of Connecticut has 29 pending office actions in Biotechnology & Pharmaceuticals. The portfolio involves 28 distinct examiners and 26 distinct art units, showing extensive dispersion across examination assignments. Prosecution management will benefit from a centralized system that preserves technical and claim-history context for each application.
RONEY, CELESTE A is the busiest examiner, with 2 pending matters. The limited concentration means that examiner-specific coordination can address only a small portion of the portfolio, while broader consistency in disclosure support and amendment practice remains important.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 6 (19%) |
| §103 only | 7 (23%) |
| §112 only | 1 (3%) |
| Double-patenting + other | 1 (3%) |
| Multi-statute (no §101) | 15 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RONEY, CELESTE A | 2 | 63.0% | +17.4% |
| TADESSE, YEWEBDAR T | 1 | 81.4% | +19.1% |
| TRUONG, CAM Y T | 1 | 82.3% | +61.4% |
| BATES, KEENAN ALEXANDER | 1 | 44.9% | +79.8% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
| STEPHENS, JACQUELINE F | 1 | 75.6% | +14.9% |
| SIRCAR, ALISHA JITENDRA | 1 | 54.8% | +51.6% |
| KAMM, JUDITH MARIE | 1 | 42.9% | +57.1% |
| TIWARI, VYOMA SHUBHAM | 1 | 32.1% | +47.4% |
| ALLEN, SARAH ELIZABETH | 1 | 56.7% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566217 | PARTICLE FILTRATION | PERRIN, CLARE M | 26d overdue |
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 18352185 | THERAPEUTIC BANDAGE | KASHYAP, ESHA PRAKASH | 15d overdue |
| 18109557 | Permeation Apparatus, System and Method | SHUMATE, ANTHONY R | 9d overdue |
| 18449499 | DEVICES FOR FORMING IN SITU MICRONEEDLES AND METHODS THEREOF | MEDWAY, SCOTT J | 27d |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 70d |
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 18041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | RONEY, CELESTE A | 16d |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 70d |
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | — |
| 18721402 | COMPOSITIONS AND METHODS FOR ESTABLISHMENT OF BOVINE-INDUCED PLURIPOTENT STEM CELLS | BATES, KEENAN ALEXANDER | — |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | — |
| 18708433 | LONG-ACTING INJECTABLE IN SITU FORMING BIODEGRADABLE IMPLANTS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | KAMM, JUDITH MARIE | — |
| 18652048 | PORCINE MUSCLE EXTRACELLULAR MATRIX-DERIVED HYDROGEL AND USES THEREOF | TIWARI, VYOMA SHUBHAM | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1613 | 2 |
| 1612 | 2 |
| 1718 | 1 |
| 2169 | 1 |
| 1631 | 1 |
| 1682 | 1 |
| 3781 | 1 |
| 3792 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | 1718 | §102§103 | Non-Final OA | — | Pending | May 20, 2025 |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 2169 | §101§103§112 | Final Rejection | 70d | Pending | May 01, 2025 |
| 18721402 | COMPOSITIONS AND METHODS FOR ESTABLISHMENT OF BOVINE-INDUCED PLURIPOTENT STEM CELLS | BATES, KEENAN ALEXANDER | 1631 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18710724 | SYSTEMS AND METHODS FOR NUCLEIC ACID EXTRACTION AND VISUAL DETECTION | JONES, CHRISTINE MICHELLE | 1682 | §101§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | 3781 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 3792 | §101§103 | Final Rejection | 23d overdue | Pending | May 08, 2024 |
| 18708433 | LONG-ACTING INJECTABLE IN SITU FORMING BIODEGRADABLE IMPLANTS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | KAMM, JUDITH MARIE | 1611 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18652048 | PORCINE MUSCLE EXTRACELLULAR MATRIX-DERIVED HYDROGEL AND USES THEREOF | TIWARI, VYOMA SHUBHAM | 1634 | §103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18630651 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ALLEN, SARAH ELIZABETH | 1637 | §112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18685958 | NON-OPIOID METHODS FOR TREATING PAIN | CESARE, JOSEPH DAVID | 1675 | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18438074 | Transcription Factor GLI1 Inhibitors and Uses Thereof | MAHLUM, JONATHAN DAVIS | 1625 | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CRAIGO, WILLIAM A | 1615 | §102§103§112DP | Final Rejection | — | Pending | Dec 11, 2023 |
| 18566217 | PARTICLE FILTRATION | PERRIN, CLARE M | 1779 | §101§102§103§112 | Final Rejection | 26d overdue | Pending | Dec 01, 2023 |
| 18285602 | FOAM BIOMATERIAL AND SYSTEMS, METHODS, AND DEVICES FOR MAKING AND USING SAME | COUGHLIN, DANIEL F | 1619 | §103 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18450305 | SYSTEMS AND METHODS FOR INFRASTRUCTURE RESILIENCE ESTIMATION AND ASSESSMENT | SCHNEE, HAL W | 2129 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18449499 | DEVICES FOR FORMING IN SITU MICRONEEDLES AND METHODS THEREOF | MEDWAY, SCOTT J | 3783 | §103§112 | Final Rejection | 27d | Pending | Aug 14, 2023 |
| 18262443 | SYNTHETIC ARTIFICIAL STEM CELLS (SASC) | KIM, DANIELLE A | 1613 | §103 | Final Rejection | 61d | Pending | Jul 21, 2023 |
| 18352185 | THERAPEUTIC BANDAGE | KASHYAP, ESHA PRAKASH | 3783 | §102§103 | Final Rejection | 15d overdue | Pending | Jul 13, 2023 |
| 18351317 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | EVANS, CHRISTOPHER RYAN | 1677 | §102§103§112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18270368 | Use of Fibroblast Growth Factor-8 For Tissue Regeneration | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18036704 | THERAPEUTICS TARGETING TRANSFORMING GROWTH FACTOR BETA FAMILY SIGNALING | ARIETI, RUTH SOPHIA | 1635 | §103§112 | Final Rejection | — | Pending | May 12, 2023 |
| 18250114 | NANOPARTICLES FOR IMAGING AND THERAPY | BASQUILL, SEAN M | 1614 | §103 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18301661 | Particle Modifiers for Multi-Drug Loaded Nanoparticles | RONEY, CELESTE A | 1612 | §102§103§112 | Final Rejection | — | Pending | Apr 17, 2023 |
| 18133366 | METAL OXIDE NANOMATERIALS | RUMP, RICHARD M | 1759 | §102§103§112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103Other | Final Rejection | 56d | Pending | Apr 05, 2023 |
| 18041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | 16d | Pending | Feb 16, 2023 |
| 18109557 | Permeation Apparatus, System and Method | SHUMATE, ANTHONY R | 1773 | §102§103§112 | Non-Final OA | 9d overdue | Pending | Feb 14, 2023 |
| 18017551 | BIOMEDICAL BIG DATA ANALYSIS PROGRAM | PLAYER, ROBERT AUSTIN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 17881387 | ASSAY COMPOUND SCREENING | FLINDERS, JEREMY C | 1684 | §101 | Final Rejection | — | Pending | Aug 04, 2022 |
| 17840869 | System and Method for Sensory Transmission Block by Electrical Stimulation of Neural Tissue | FEDORKY, MEGAN TAYLOR | 3796 | §103 | Final Rejection | — | Pending | Jun 15, 2022 |
| 17487661 | BIODEGRADABLE MICRONEEDLE SYSTEM WITH SUSTAINED RELEASE | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103Other | Final Rejection | 29d | Pending | Sep 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Connecticut has 31 pending office actions as of October 2026, spread across 28 art units and 30 examiners.
Celeste A Roney has the most, with 2 of University of Connecticut's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
